Details for Patent: 10,912,765
✉ Email this page to a colleague
Which drugs does patent 10,912,765 protect, and when does it expire?
Patent 10,912,765 protects UPNEEQ and is included in one NDA.
This patent has twenty-eight patent family members in twenty-three countries.
Summary for Patent: 10,912,765
Title: | Compositions and methods for non-surgical treatment of ptosis |
Abstract: | Provided are pharmaceutical compositions, and methods of use of the compositions, for the non-surgical treatment of ptosis (eyelid droop). In one embodiment the composition includes oxymetazoline 0.1% formulated for topical administration to an eye. In one embodiment the composition includes a synergistic combination of oxymetazoline and phenylephrine, formulated for topical administration to an eye. Oxymetazoline alone causes no pupillary dilation (mydriasis), and a synergistic combination of oxymetazoline and phenylephrine induces no clinically significant mydriasis. In addition to providing desirable cosmetic effects, the compositions and methods of the invention can improve visual fields otherwise compromised by ptosis. |
Inventor(s): | Silverberg; Mark (Santa Barbara, CA) |
Assignee: | VOOM, LLC (Santa Barbara, CA) |
Application Number: | 16/577,262 |
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 10,912,765
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Rvl Pharms | UPNEEQ | oxymetazoline hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 212520-001 | Jul 8, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | METHOD OF TREATING BLEPHAROPTOSIS | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,912,765
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2012223615 | ⤷ Try a Trial | |||
Brazil | 112013022094 | ⤷ Try a Trial | |||
Canada | 2827285 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |